Why the study?
Does high-dose steroid or IVIG therapy reduce major in-hospital complications, late heart failure hospitalization, and long-term mortality in pediatric patients with acute myocarditis?
Does high-dose steroid or IVIG therapy reduce major in-hospital complications, late heart failure hospitalization, and long-term mortality in pediatric patients with acute myocarditis?
High-dose steroid or IVIG therapy does not appear to significantly improve in-hospital or long-term outcomes in pediatric acute myocarditis.
High-dose steroid or IVIG should not yet change practice in pediatric acute myocarditis; leaves open efficacy questions for randomized trials.
The present study revealed that high-dose steroid or IVIG therapy had no significant effects on major in-hospital complications, late heart failure hospitalization, and long-term mortality.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: